Evaluation of the Safety of Sanyak (Dioscoreae Rhizoma) Pharmacopuncture According to the Extraction Method: A Double-blind Randomized Controlled Trial | Zendy

Min-kyung Ko | Zendy; Kwon-Eui Hong | Zendy

Open Access

Evaluation of the Safety of Sanyak (Dioscoreae Rhizoma) Pharmacopuncture According to the Extraction Method: A Double-blind Randomized Controlled Trial

Author(s) -

Min-kyung Ko,

Kwon-Eui Hong

Publication year - 2012

Publication title -

journal of acupuncture and meridian studies

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.374

H-Index - 32

eISSN - 2093-8152

pISSN - 2005-2901

DOI - 10.1016/j.jams.2012.12.003

Subject(s) - medicine , urinalysis , hematocrit , double blind , randomized controlled trial , anesthesia , urine , alternative medicine , pathology , placebo

The study was conducted to evaluate the safety of Sanyak (Dioscoreae rhizoma) pharmacopuncture by injecting to healthy participants. Among the subjective symptoms, pain after the injection was statistically significant in the group injected with alcohol extract of Sanyak. The mean platelet volume and blood in the urinalysis after the injections were statistically significant between groups. After injections, the total protein level in liver function tests and hematocrit changed significantly. However, all of these changes were within normal limits, and Sanyak pharmacopuncture did not cause any severe physical responses or subjective symptoms and may, therefore, be considered safe.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research